ARQTARQTArcutis Biotherapeutics, Inc. - Common stock
2 members of Congress disclosed 6 transactions in ARQT between Jun 15, 2022 and May 29, 2026.
Price, with congressional trades marked
ARQT $25.27latest
-14%
Gilbert Ray Cisneros, Jr., Democrat
+7%
Gilbert Ray Cisneros, Jr., Democrat
+18%
Gilbert Ray Cisneros, Jr., Democrat
Marked trades (3)
| Traded | Member | Amount | Adj. close | ARQT since | SPY since | Difference | |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Gilbert Ray Cisneros, Jr. (D) | sell | ~$8K | $29.44 | -14.1% | +13.1% | -27.3% |
| Mar 3, 2026 | Gilbert Ray Cisneros, Jr. (D) | buy | ~$8K | $23.58 | +7.2% | +14.3% | -7.1% |
| May 29, 2026 | Gilbert Ray Cisneros, Jr. (D) | buy | ~$8K | $21.48 | +17.7% | +2.5% | +15.2% |
Prices are dividend- and split-adjusted, so “adj. close” is not necessarily what the stock printed that day. The horizon runs to the latest close, so rows with different trade dates are not comparable to each other — and none of these is the benchmark-relative, fixed-window alpha the leaderboard ranks on.
6
Transactions
4 buys · 2 sells
2
Members
$48K
Est. volume
2D / 0R
Party split
distinct members
Who traded it
| Member | Trades | Buys / Sells | Est. volume |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D-CA | 3 | 2 / 1 | ~$24K |
| Josh GottheimerD-NJ | 3 | 2 / 1 | ~$24K |
Transactions
6| Member | Type | Amount | Traded | Disclosed | Source |
|---|---|---|---|---|---|
| Buy | $1K – $15K | May 29, 2026 | Jun 8, 2026 10d | filing | |
| Buy | $1K – $15K | Mar 3, 2026 | Apr 7, 2026 35d | filing | |
| Sell (part) | $1K – $15K | Dec 11, 2025 | Jan 12, 2026 32d | filing | |
| Selljoint | $1K – $15K | Sep 15, 2023 | Oct 15, 2023 30d | filing | |
| Buyjoint | $1K – $15K | Apr 17, 2023 | May 19, 2023 32d | filing | |
| Buyjoint | $1K – $15K | Jun 15, 2022 | Jul 22, 2022 37d | filing |
Disclosures are filed up to 45 days after a trade, so this is a record rather than a signal. Amounts are bracket midpoints. Symbols are recorded as they existed on the trade date and mapped forward where a company was renamed.